Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2029

Conditions
Tricuspid RegurgitationTricuspid Valve DiseaseTricuspid Valvular Disorders
Interventions
DEVICE

VDyne Transcatheter Tricuspid Valve Replacement System

The study investigational device is the VDyne Transcatheter Tricuspid Valve Replacement System.

Trial Locations (16)

1090

RECRUITING

Universitätsklinik für Herzchirurgie Medizinische Universität Wien, Vienna

2010

RECRUITING

St. Vincent Hospital, Sydney

3204

RECRUITING

Waikato Hospital, Hamilton

10967

RECRUITING

Vivantes Klinik Am Urban, Berlin

18057

RECRUITING

Universitätsmedizin Rostock, Rostock

24105

RECRUITING

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel

28222

RECRUITING

Hospital Universitario Puerta de Hierro, Madrid

Unknown

RECRUITING

Flinders Medical Centre, Adelaide

RECRUITING

Princess Alexandra Hospital, Brisbane

RECRUITING

The Prince Charles Hospital, Brisbane

RECRUITING

Monash Heart, Melbourne

RECRUITING

Johannes Kepler University Linz - JKU, Linz

RECRUITING

AZ Sint Jan Hospital, Bruges

RECRUITING

Nemocnice AGEL Podlesi Trinec, Třinec

RECRUITING

Herz & Diabeteszentrum Nordrhein Westfalen, Bad Oeynhausen

RECRUITING

Hospital Clínico San Carlos, Madrid

All Listed Sponsors
lead

VDyne, Inc.

INDUSTRY